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Summary
The mammalian APOBEC3 family of cytidine deami-
nases includes several members that possess potent
antiretroviral activity. Human APOBEC3F and APO-
BEC3G are specifically incorporated into human im-
munodeficiency virus type 1 (HIV-1) progeny virions in
the absence of virion infectivity factor (Vif), where
they deaminate deoxycytidine to deoxyuridine on the
minus strand of nascent reverse transcripts. Editing
of the HIV-1 cDNA leads to its degradation or to G to
A hypermutation of the integrated provirus [1–8].
Here, we show that APOBEC3 proteins also restrict
the activity of a distantly related long terminal repeat
(LTR) retrotransposon. When expressed in the yeast
Saccharomyces cerevisiae, human APOBEC3C, APO-
BEC3F, or APOBEC3G or mouse APOBEC3 potently
inhibit replication of the Ty1 LTR retrotransposon.
APOBEC3G interacts with Ty1 Gag and is packaged
into Ty1 virus-like particles (VLPs) by a mechanism
that closely resembles the one it uses to enter HIV-1
virions. Expression of APOBEC3G results in a reduced
level of Ty1 cDNA integration and G to A editing of
integrated Ty1 cDNA. Our findings indicate that APO-
BEC3G restricts Ty1 and HIV-1 by similar mechanisms
and suggest that the APOBEC3 proteins target a sub-
stantially broader spectrum of retroelements than
previously appreciated.
Results and Discussion
LTR retrotransposons and retroviruses are related fami-
lies of mobile elements that transpose through an RNA
intermediate. They are characterized by the presence
of long-terminal repeats (LTRs), orthologous gag and
pol genes, and common mechanisms of expression
and replication. The major difference between these
two classes of retroelements is that retroviral genomes
encode an envelope glycoprotein (Env) that promotes
the dissemination of viral particles to new host cells.
Evidence from several lines of investigation favors the
hypothesis that retroviruses evolved from LTR retro-*Correspondence: curcio@wadsworth.orgtransposons in part by acquisition of an env-like gene
(reviewed in [9]). Given the evolutionary relationship be-
tween LTR retrotransposons and retroviruses, it seems
reasonable to hypothesize that they share susceptibility
to mechanisms of innate regulation by eukaryotic host
cells [10–12]. However, little evidence for this idea
exists.
The human genome encodes seven APOBEC3 genes,
which are the products of a recent expansion from a
single mammalian APOBEC3 gene [13, 14]. Human
APOBEC3B (hA3B), APOBEC3C (hA3C), APOBEC3F
(hA3F), APOBEC3G (hA3G), and mouse APOBEC3 (mA3)
restrict the replication of distinct classes of primate len-
tiviruses [2, 5–7, 15]. APOBEC3G is also active against
other retroviruses and even the hepadnavirus hepatitis
B virus but does not inhibit the abundant LINE-1 non-
LTR retrotransposon, which, unlike LTR retroelements,
is reverse transcribed in the nucleus [2, 4, 16, 17]. Given
these observations, we asked whether the antiretroviral
activity of APOBEC3G proteins might extend to LTR ret-
rotransposons. To test this possibility, we focused on
the Ty1 LTR retrotransposon in the yeast Saccharo-
myces cerevisiae. Ty1 belongs to the Ty1/copia clade
of LTR retrotransposons, which is distantly related to
mammalian retroviruses [18]. The transposition of Ty1,
unlike most other LTR retrotransposons, can be de-
tected when the element is located in its normal
context in the chromosome and driven from its own
promoter. Hence, it is an ideal system for analyzing
host-factor regulation.
APOBEC3 open-reading frames, fused to the GAL1
promoter on the pYES2 expression plasmid and to a
HA-epitope at the C terminus, were introduced into a
yeast strain containing a chromosomal Ty1 element
marked by the retrotransposition indicator gene, his3AI.
The his3AI gene, which is defective due to an antisense
intron within the HIS3 coding sequence, is contained
within the 3#UTR of Ty1 in the opposing transcriptional
orientation [19]. Therefore, the intron in his3AI can be
spliced from the Ty1his3AI transcript. When this spliced
RNA is used as a template for retrotransposition, a
functional HIS3 gene is recreated in the newly inte-
grated element, allowing cells that sustain a retrotrans-
position event to be scored as His+ prototrophs.
The frequency of His+ prototroph formation was mea-
sured in strain JC3212 expressing hA3C, hA3F, hA3G,
or mA3 (Figure 1A). Remarkably, expression of any of
the APOBEC3 proteins reduced Ty1his3AI transposition
to 2% or less of the activity in the strain lacking APO-
BEC (Figure 1B). Transposition was not inhibited when
the GAL1 promoter was repressed by growth in glucose
(data not shown). Mutant hA3G proteins harboring sub-
stitutions predicted to disrupt one or both of the two
zinc binding catalytic sites (hA3G-M1: S95A, P96A,
C97A; hA3G-M2: S286A, P287A, C288A; hA3G-M1M2:
S95A, P96A, C97A, S286A, P287A, C288A) eliminated
most of the inhibitory activity of hA3G, suggesting that
the deaminase activity of hA3G is critical for inhibition
of retrotransposition. The residual inhibitory activity of
these hA3G mutants may be due to a deaminase-inde-
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mFigure 1. Human and Mouse APOBEC3 Proteins Specifically Inhibit
Ty1 Retrotransposition
f
(A) Western blot analysis of whole cell lysates from strain JC3212 o
induced for expression of the HA-tagged APOBEC3 protein indi-
acated, or no APOBEC3, with anti-HA antibodies.
p(B) Relative frequency of Ty1his3AI transposition in three trans-
Gformants harboring pYES2 (no APOBEC) or pYES2 with the APO-
BEC3 allele indicated in strain JC3212. The percentage of 6
Ty1his3AI transposition is the average frequency of transposition in b
APOBEC3 plasmid transformants divided by the average frequency W
of Ty1his3AI transposition in pYES2 transformants. a
(C) Similar to (B) except that strain JC297 containing Ty1his3AI, or
wstrain JC560 harboring Ty2his3AI, was used in the analysis. Error
(bars, ± standard error.
t
tpendent function of hA3G [20] or to an indirect effect W
of expressing high levels of the hA3G protein on a mod- h
ulator of Ty1 transposition.The ability of hA3F and hA3G to restrict HIV-1 replica-
ion is correlated with the specific incorporation of
hese proteins into HIV-1 virions [1, 6, 8]. If APOBEC3
roteins are specifically incorporated into Ty1 VLPs,
hen they might have disparate effects on transposition
f other LTR retrotransposons in yeast, depending on
heir relative levels of VLP incorporation. To test this
ypothesis, we examined the ability of APOBEC3 pro-
eins to block transposition of Ty2 elements, which are
ore than 90% homologous to Ty1 but show a signifi-
ant level of divergence within gag [21, 22]. Derivatives
f pYES2 containing various APOBEC3-HA alleles
ere introduced into yeast strains harboring either a
y1his3AI element (strain JC297) or a Ty2his3AI element
strain JC560). Similar to the results observed with
train JC3212 (Figure 1B), expression of hA3G, hA3F, or
A3 reduced Ty1his3AI transposition to between 0.8%
nd 4.5% of the activity in strain JC297 lacking APO-
EC (Figure 1C). In contrast, each of the APOBEC3 pro-
eins reduced Ty2his3AI transposition only to 14% to
2% of the activity in strain JC560 lacking APOBEC.
ecause Ty2 RNA and transposition are both lower
han those of Ty1 [23], these data argue against a pas-
ive interaction between hA3G and Ty cDNA or RNA;
ather, they raise the possibility that APOBEC3 proteins
re preferentially incorporated into Ty1 VLPs.
To test this idea, we determined whether hA3G
osediments with Ty1 VLPs in sucrose gradients. Cell
ysate prepared from a strain expressing hA3G-HA was
ractionated on two consecutive sucrose gradients. The
58 and p54 Ty1 Gag proteins and the p190 Ty1 Gag-
ol fusion protein were detected in four fractions col-
ected near the bottom of the second gradient by West-
rn blot analysis with anti-VLP antisera (Figure 2A).
uman A3G cosedimented with Ty1 VLPs in the two
ensest fractions of the four containing Ty1 VLPs. In
ontrast, hA3G was not present in these dense frac-
ions when expressed in an spt3 strain, which lacks Ty1
LPs because of the absence of a factor, Spt3, required
or Ty1 transcription (Figure 2B). Therefore, the inhibi-
ion of Ty1 transposition by hA3G may reflect the pack-
ging of hA3G into Ty1 VLPs.
Packaging of hA3G into HIV-1 virions is mediated by
specific interaction between hA3G and the HIV-1 Gag
rotein [24–27]. We used glutathione-S-transferase
GST)-based coprecipitation experiments to determine
hether hA3G interacts with Ty1 Gag (Figure 3A). Hu-
an 293T cells that expressed a HA epitope-tagged
orm of either hA3G (Figure 3A, top, lanes 1, 3, and 5)
r β-arrestin (a cytoplasmic human protein that serves
s a negative control; lanes 2, 4, and 6) and coex-
ressed nonfused GST (bottom, lanes 1 and 2), HIV-1
ST-Gag (lanes 3 and 4), or Ty1 GST-Gag (lanes 5 and
) were lysed, and the fraction of each lysate that
ound to glutathione-Sepharose beads was purified.
estern analysis of the bound fractions with anti-HA
ntibodies revealed that hA3G was strongly associated
ith HIV-1 GST-Gag (middle, lane 3) and Ty1 GST-Gag
lane 5), but not with non-fused GST (lane 1). In con-
rast, HA-tagged β-arrestin was not coprecipitated by
he GST-Gag fusion proteins (middle, lanes 2, 4, and 6).
e have also observed coimmunoprecipitation of
A3G with Ty1 Gag in yeast (data not shown).
Incorporation of APOBEC3G into HIV-1 virion par-
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663Figure 2. Human APOBEC3G Cosediments
with Ty1 VLPs
(A) Western blot analysis of sucrose gradient
fractions of cell lysates from strain JC3212
expressing APOBEC3G or no APOBEC with
rabbit antiserum specific for Ty1 Gag (top) or
anti-HA antibodies (bottom). For each strain,
10 ug of whole cell lysate (IN), 7 µl (1×) and
0.7 µl (0.1×) of the 45% fraction of the first
sucrose gradient and 11.5 µl of the first and
then every third fraction of the second 20%
to 60% gradient (20%–60%) were analyzed.
(B) Similar to (A) except an spt3 strain ex-
pressing APOBEC3G was analyzed with
anti-HA antibodies.ing four tandem high-affinity MS2 target sites [28]. So findings support the hypothesis that hA3G deaminates
Figure 3. Ty1 Gag Binds APOBEC3G Specifi-
cally
(A) Western blot analysis of whole cell ly-
sates from human 293T cells cotransfected
with pK-GST (lanes 1 and 2), pK/HIVGAG-
GST (lanes 3 and 4), or pK/TYA-GST (lanes 5
and 6) and with pK-h3G-HA (lanes 1, 3, and
5) or pK-ßARR-HA (lanes 2, 4, and 6) by
using anti-HA antibodies (top, input) or anti-
GST antibodies (bottom). The fraction of
each lysate that bound to glutathione-Seph-
arose beads was subjected to Western
analysis with anti-HA antibodies (middle,
bound).
(B) 293T cells were cotransfected with
phA3G-HA together with pK/TY1GAG-GST
(lanes 1 and 2) or pK/MS2-GST and
pDM128/4XMS2 (lanes 3 and 4). Binding
assays were performed as described in (A) except that the cell lysate was incubated at 37°C for 10 min in the presence (lanes 2 and 4) or
absence (lanes 1 and 3) of 50 µg of RNase A, prior to addition of the glutathione-Sepharose beads.ticles is mediated by the nucleocapsid domain of HIV-1
Gag, one of whose functions is to bind and recruit the
HIV-1 RNA genome into virion particles [24–27]. Indeed,
binding of APOBEC3G by HIV-1 Gag also requires the
presence of RNA, although nonspecific, cellular RNAs
function as well as viral RNA [24, 25]. It has therefore
been proposed that APOBEC3G exploits the essential
RNA packaging step to gain entry into retroviral par-
ticles [25].
To test whether RNA also plays a role in Ty1 Gag
binding by APOBEC3G, we asked whether RNase treat-
ment would block Ty1 Gag binding by APOBEC3G, as
previously reported for HIV-1 Gag [24, 25]. Indeed, as
shown in Figure 3B, lanes 1 and 2, RNase treatment
entirely prevented this interaction. As a control for the
specificity of this interaction, a fusion protein con-
sisting of GST linked to the bacteriophage MS2 coat
protein, a well-characterized RNA binding protein
active in human cells (27), was tested for interaction
with APOBEC3G in transfected cells. As shown in Fig-
ure 3B, lanes 3 and 4, no interaction was observed. Of
note, these 293T cells were also transfected with an
expression vector, pDM128/4XMS2, that we have pre-
viously shown expresses high levels of an mRNA bear-the lack of any interaction between APOBEC3G and
GST-MS2 noted in Figure 3B is unlikely to be due to the
absence of RNAs able to interact with the GST-MS2
protein. Taken together, these findings demonstrate
that hA3G forms a specific ribonucleoprotein complex
with Ty1 Gag leading to the packaging of hA3G into
Ty1 VLPs.
Because hA3G induces C to T hypermutation on the
minus strand of newly synthesized HIV-1vif cDNA, we
asked whether hA3G also induces C to T editing in
Ty1HIS3 cDNA. Because Ty1 cDNA is in very low abun-
dance [29], we analyzed integrated Ty1HIS3 cDNA from
His+ prototrophs to obtain independent cDNA se-
quences. A fragment of Ty1HIS3 cDNA was amplified
with one primer that recognizes the splice junction of
HIS3 and one primer that hybridizes in Ty1 pol, and the
Ty1 pol region was sequenced. Eleven C to T substitu-
tions and one G to A substitution in 12,227 nucleotides
sequenced were detected on the minus strand of
Ty1HIS3 cDNA in strains expressing hA3G. Between
one and six C to T substitutions were found on five of
seventeen cDNA templates. In contrast, zero substitu-
tions in 14,559 nucleotides sequenced from 21 Ty1HIS3
templates were detected in strains lacking hA3G. These
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ascripts, although the level of editing appears to be
lower than that seen on HIV-1 cDNA [2–5]. u
DAPOBEC3G preferentially recognizes the target se-
quence CCCA and does not effectively edit C residues i
wflanked by 5# G residues. (The edited C residue is un-
derlined.) The C residue at position −1 is the most s
bhighly favored, but T at position −1 is recognized at a
low frequency [7]. Analysis of nucleotides adjacent to ~
[the edited C residues in Ty1 indicated that APOBEC3G
has a relaxed target specificity in yeast (Figure 4A). At T
Eposition −1, T or C is preferred, and at position −2,
either A or C is preferred. We note that G residues were T
tnot detected at either position. This somewhat relaxed
specificity may reflect the fact that Ty1 transposition i
iassays are conducted at 20°C, which is significantly
lower than the temperature of 37°C at which HIV-1 repli- i
scation is assayed. This reduced temperature may stabi-
lize the binding of hA3G to less favorable consensus p
rsequences.
It is possible that the low level of editing we observed
oin Ty1 cDNAs after expression of hA3G is a conse-
quence of having selected for a functional HIS3 gene, t
cwhich may have enriched for cDNAs that escaped edit-
ing. However, Ty1 cDNA extracted from sucrose-gradi- e
hent-purified Ty1 VLPs from strains expressing hA3G
also had a similarly low but significant level of C to T p
atransitions on the minus strand (data not shown). A sec-
ond possibility is that hypermutated Ty1 cDNA might e
dbe targeted for degradation, as has been observed for
HIV-1, and therefore would be unavailable for integ- t
aration. Alternatively, editing in the primer binding site or
U3 region of the LTR, which has also been observed in t
iHIV-1 [30], might interfere with plus strand cDNA syn-
thesis or integration, respectively. To determine if ex-
Apression of APOBEC3G blocks Ty1 cDNA integration or
a step prior to it, we measured the level of de novo r
tintegration into regions upstream of tRNA genes, whichFigure 4. Human APOBEC3G Edits C Resi-
dues in Ty1 cDNA and Inhibits Integration of
Total Ty1 cDNA Upstream of tRNAgly Genes
(A) Sequence context for eleven indepen-
dent dC deaminations on the minus strand
of Ty1 cDNA. The fraction of events (ex-
pressed as a percentage) in which a particu-
lar base (A, C, G, or T) was found at the −2,
−1, or +1 position relative to the deaminated
C residue is indicated.
(B) Top, PCR analysis of genomic DNA from
a wild-type (WT) strain expressing no APO-
BEC protein (−) or the APOBEC3 protein indi-
cated, or from a tec1D strain lacking APO-
BEC, with one primer that hybridizes in the
Ty1 pol domain (T) and one that hybridizes
to 16 tRNAgly genes (S). PCR reactions were
terminated after 29, 31, 33, or 35 cycles
(black triangles). Control PCR reactions con-
tained one primer (T or S). Bottom, PCR re-
actions of the TEL1 gene terminated after 17,
19, 21, or 23 cycles, as a control for equiva-
lent template concentrations.re preferred sites of Ty1 integration, in the presence or
bsence of hA3G. Strains were grown at 20°C to allow
nselected Ty1 transposition events to occur. Genomic
NA was prepared, and total Ty1 element integration
nto the upstream region of any of the 16-tRNAgly genes
as detected by PCR (Figure 4B). As anticipated, the
train lacking hA3G yielded a ladder of PCR products
etween 0.5 kb and 1.2 kb (representing Ty1 insertions
100 to 800 bp upstream of one or more tRNAgly genes
31]). The appearance of this ladder was dependent on
y1 transcription, which is reduced in a tec1D mutant.
xpression of hA3G sharply reduced the appearance of
y1 integration bands. Importantly, amino-acid substi-
utions in the catalytic domains of hA3G restored Ty1
ntegration upstream of tRNAgly genes. These findings
ndicate that the cytidine deaminase activity of hA3G
nterferes with cDNA integration or a step prior to it,
uch as cDNA synthesis or stability. Therefore, we hy-
othesize that heavily deaminated Ty1 cDNA may be
apidly degraded in vivo.
The HIV-1 protein Vif suppresses the antiviral activity
f hA3G by targeting it for ubiquitination and degrada-
ion [32–34]. Therefore, we determined whether HIV-1Vif
ould restore Ty1 retrotransposition when hA3G was
xpressed. Although Vif was expressed at high levels,
A3G inhibited Ty1his3AI transposition equally in its
resence or absence (data not shown). In human cells,
Vif mutant that interacts with hA3G, but not the Cul5-
longin B/C E3-ubiquitin ligase, does not induce degra-
ation of hA3G. Hence, our results may be explained by
he fact that the yeast homologs of Cul5 and elongins B
nd C are not highly conserved. It is possible, however,
hat the function of Vif can be reconstituted in yeast by
ntroduction of one or more of these human cofactors.
In summary, we have shown that human and mouse
POBEC3 proteins can inhibit not only exogenous ret-
oviruses such as HIV-1 but also the yeast Ty1 retro-
ransposon, despite the great evolutionary distance be-
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665tween these retroelements. Moreover, Ty1 Gag, like
HIV-1 Gag, interacts specifically with APOBEC3G, and
both interactions are RNA dependent (Figure 3). Inter-
estingly, the nucleocapsid domain of HIV-1 Gag, which
mediates its interaction with hA3G [24, 25, 27], is highly
divergent from the nucleocapsid domain of Ty1 Gag.
Thus, APOBEC3 proteins may recognize a conserved
structural intermediate involved in RNA packaging into
both HIV-1 virion particles and Ty1 VLPs, rather than a
conserved sequence. Overall, these data argue that Ty1
and retroviral Gag proteins have not only conserved
functions critical for their replication, such as genomic
RNA packaging, but also their susceptibility to the
APOBEC3 family of innate resistance factors. This re-
sult supports the idea that yeast cell factors that re-
press Ty1 transposition may also be candidates for in-
nate regulators of exogenous retroviral infection in
mammals.
Although the ancient Ty1/copia elements have yet to
be identified in mammalian genomes, the more recent
superfamily of Ty3/gypsy LTR retrotransposons as well
as endogenous retroviruses constitute a significant
fraction of typical mammal genomes [35, 36]. Moreover,
steady retrotransposition of these elements over time
is likely to be more deleterious to genome integrity than
sporadic instances of retroviral infection. Our findings,
taken together with a recent study demonstrating that
hA3G inhibits retrotransposition of endogenous retro-
viruses in mice [37], suggest that APOBEC3 proteins
can target a surprisingly broad range of LTR retroele-
ments. Hence, mammalian APOBEC3 proteins may
have evolved originally to restrict the transposition of
LTR retrotransposons in these genomes, with inhibition
of retroviral infection either being fortuitous or appear-
ing later in evolution.
Supplemental Data
Supplemental Experimental Procedures are available with this arti-
cle online at http://www.current-biology.com/cgi/content/full/15/7/
661/DC1/.
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